Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents - Université Claude Bernard Lyon 1 Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2016

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

Didier Auboeuf
  • Fonction : Auteur
  • PersonId : 944610
T. Commes
Mark J. Cowley
  • Fonction : Auteur
  • PersonId : 1090158
François Artiguenave
  • Fonction : Auteur
  • PersonId : 908642
Jean-François Deleuze
  • Fonction : Auteur
  • PersonId : 1015006
Claude Preudhomme
  • Fonction : Auteur
  • PersonId : 899523
Seishi Ogawa
  • Fonction : Auteur

Résumé

The cytidine analogues azacytidine and 5-aza-2'-deoxycytidine (decitabine) are commonly used to treat myelodysplastic syndromes, with or without a myeloproliferative component. It remains unclear whether the response to these hypomethylating agents results from a cytotoxic or an epigenetic effect. In this study, we address this question in chronic myelomonocytic leukaemia. We describe a comprehensive analysis of the mutational landscape of these tumours, combining whole-exome and whole-genome sequencing. We identify an average of 14±5 somatic mutations in coding sequences of sorted monocyte DNA and the signatures of three mutational processes. Serial sequencing demonstrates that the response to hypomethylating agents is associated with changes in DNA methylation and gene expression, without any decrease in the mutation allele burden, nor prevention of new genetic alteration occurence. Our findings indicate that cytosine analogues restore a balanced haematopoiesis without decreasing the size of the mutated clone, arguing for a predominantly epigenetic effect.
Fichier principal
Vignette du fichier
IRMB 13_P39_ Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents_ncomms10767.pdf (2.35 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03130526 , version 1 (03-02-2021)

Licence

Paternité

Identifiants

Citer

Jane Merlevede, Nathalie Droin, Tingting Qin, Kristen Meldi, Kenichi Yoshida, et al.. Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents. Nature Communications, 2016, 7 (1), ⟨10.1038/ncomms10767⟩. ⟨hal-03130526⟩
145 Consultations
41 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More